ArticleHaematologica2020

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.

Louise de Swart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.